These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 15767042
1. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells. Lovekamp-Swan T, Chaffin CL. Mol Cell Endocrinol; 2005 Apr 15; 233(1-2):15-24. PubMed ID: 15767042 [Abstract] [Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines. Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF. Acta Pharmacol Sin; 2005 Jun 15; 26(6):753-61. PubMed ID: 15916743 [Abstract] [Full Text] [Related]
3. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells. Bruemmer D, Yin F, Liu J, Berger JP, Sakai T, Blaschke F, Fleck E, Van Herle AJ, Forman BM, Law RE. Circ Res; 2003 Aug 22; 93(4):e38-47. PubMed ID: 12881480 [Abstract] [Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth. Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG. J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072 [Abstract] [Full Text] [Related]
5. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC. Hepatology; 2006 Jan 01; 43(1):134-43. PubMed ID: 16374840 [Abstract] [Full Text] [Related]
6. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma. Shiau CW, Yang CC, Kulp SK, Chen KF, Chen CS, Huang JW, Chen CS. Cancer Res; 2005 Feb 15; 65(4):1561-9. PubMed ID: 15735046 [Abstract] [Full Text] [Related]
7. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats. Cao Z, Ye P, Long C, Chen K, Li X, Wang H. Pharmacology; 2007 Feb 15; 79(3):184-92. PubMed ID: 17356310 [Abstract] [Full Text] [Related]
8. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. Yu HN, Lee YR, Noh EM, Lee KS, Kim JS, Song EK, Han MK, Lee YC, Kwon KB, Lee SJ, Youn HJ, Jung SH. Cell Biol Int; 2008 Aug 15; 32(8):906-12. PubMed ID: 18474441 [Abstract] [Full Text] [Related]
9. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells. Li M, Lee TW, Yim AP, Mok TS, Chen GG. J Cell Physiol; 2006 Nov 15; 209(2):428-38. PubMed ID: 16883598 [Abstract] [Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS, Chen WC, Bai X, Wang YD. J Dig Dis; 2007 May 15; 8(2):82-8. PubMed ID: 17532820 [Abstract] [Full Text] [Related]
11. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro. Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW. Ann Hematol; 2007 Mar 15; 86(3):173-83. PubMed ID: 17089125 [Abstract] [Full Text] [Related]
12. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M, Wolf G. Am J Nephrol; 2007 Mar 15; 27(4):425-34. PubMed ID: 17622750 [Abstract] [Full Text] [Related]
13. Expression of mitochondria-dependent apoptosis genes (p53, Bax, and Bcl-2) in rat granulosa cells during follicular development. Choi D, Hwang S, Lee E, Yoon S, Yoon BK, Bae D. J Soc Gynecol Investig; 2004 Jul 15; 11(5):311-7. PubMed ID: 15219885 [Abstract] [Full Text] [Related]
14. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S. Mol Pharmacol; 2008 Oct 15; 74(4):952-63. PubMed ID: 18599600 [Abstract] [Full Text] [Related]
15. Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation. Nagasawa E, Abe Y, Nishimura J, Yanase T, Nawata H, Muta K. Exp Hematol; 2005 Aug 15; 33(8):857-64. PubMed ID: 16038777 [Abstract] [Full Text] [Related]
16. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway. Xiao Y, Yuan T, Yao W, Liao K. FEBS J; 2010 Feb 15; 277(3):687-96. PubMed ID: 20050918 [Abstract] [Full Text] [Related]
17. Effect of troglitazone on CYP1A1 induction. Kim HG, Han EH, Jeong HG. Toxicology; 2008 Apr 18; 246(2-3):166-71. PubMed ID: 18308446 [Abstract] [Full Text] [Related]
18. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages. Ringseis R, Schulz N, Saal D, Eder K. J Nutr Biochem; 2008 Sep 18; 19(9):594-603. PubMed ID: 18155510 [Abstract] [Full Text] [Related]
19. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Cheng Y, Ping J, Xu LM. Chin Med J (Engl); 2007 May 05; 120(9):794-801. PubMed ID: 17531121 [Abstract] [Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation. Yang CC, Wang YC, Wei S, Lin LF, Chen CS, Lee CC, Lin CC, Chen CS. Cancer Res; 2007 Apr 01; 67(7):3229-38. PubMed ID: 17409431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]